Inventiva S.A. (IVA)
NASDAQ: IVA · Real-Time Price · USD
4.970
-0.160 (-3.12%)
At close: May 1, 2026, 4:00 PM EDT
4.960
-0.010 (-0.20%)
After-hours: May 1, 2026, 6:44 PM EDT
Inventiva Market Cap
Inventiva has a market cap or net worth of $1.05 billion as of May 1, 2026. Its market cap has increased by 209.50% in one year.
Market Cap
1.05B
Enterprise Value
1.20B
1-Year Change
209.50%
Ranking
Category
Stock Price
$4.97
Market Cap Chart
Since October 26, 2018, Inventiva's market cap has increased from $151.00M to $1.05B, an increase of 595.52%. That is a compound annual growth rate of 29.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2026 | 1.05B | 18.69% |
| Dec 31, 2025 | 884.84M | 309.83% |
| Dec 31, 2024 | 215.91M | -7.64% |
| Dec 29, 2023 | 233.77M | 16.05% |
| Dec 30, 2022 | 201.44M | -63.07% |
| Dec 31, 2021 | 545.53M | -0.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fortrea Holdings | 1.14B |
| UroGen Pharma | 1.12B |
| EyePoint | 1.11B |
| Omeros | 1.08B |
| Xeris Biopharma Holdings | 1.08B |
| Aktis Oncology | 1.07B |
| Septerna | 1.06B |
| Geron | 1.01B |